Grice Sophie, Hammond Sean, Hampson Lucy, Wagner Annette, Naisbitt Dean J
Department of Pharmacology and Therapeutics, University of Liverpool, Sherrington Building, Ashton Street, Liverpool L69 3GE, United Kingdom.
ApconiX, Alderley Edge SK10 4TG, U.K.
Chem Res Toxicol. 2024 Sep 16;37(9):1484-1487. doi: 10.1021/acs.chemrestox.4c00225. Epub 2024 Sep 4.
Proton pump inhibitors (PPIs) are a commonly used class of drugs with a good safety profile. However, their use is associated with rare cases of severe skin reaction. Herein, we present details of a patient who developed two episodes of omeprazole-induced delayed-onset hypersensitivity (atypical drug reaction with eosinophilia and systemic symptoms [DRESS]). Lymphocytes from the patient were stimulated to proliferate and secrete cytokines and cytolytic molecules when treated with the drug. T-cell cross-reactivity was observed with structurally related PPIs. Hence, other PPIs have the potential to cause further serious immune-related adverse events in patients who present with hypersensitivity to a primary PPI.
质子泵抑制剂(PPIs)是一类常用药物,安全性良好。然而,其使用与罕见的严重皮肤反应病例有关。在此,我们介绍一名患者的详细情况,该患者出现了两例奥美拉唑诱发的迟发性超敏反应(伴有嗜酸性粒细胞增多和全身症状的非典型药物反应[DRESS])。用该药物处理时,患者的淋巴细胞被刺激增殖并分泌细胞因子和溶细胞分子。观察到与结构相关的质子泵抑制剂存在T细胞交叉反应性。因此,对于对一种主要质子泵抑制剂过敏的患者,其他质子泵抑制剂有可能导致进一步严重的免疫相关不良事件。